Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-25-000046
Filing Date
2025-08-06
Accepted
2025-08-06 17:16:57
Documents
95
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tvtx-20250630.htm   iXBRL 10-Q 1701900
2 EX-10.2 tvtx-06302025x10qxex102.htm EX-10.2 32108
3 EX-31.1 tvtx-06302025x10qxex311.htm EX-31.1 12712
4 EX-31.2 tvtx-06302025x10qxex312.htm EX-31.2 12410
5 EX-32.1 tvtx-06302025x10qxex321.htm EX-32.1 8769
6 EX-32.2 tvtx-06302025x10qxex322.htm EX-32.2 8849
12 GRAPHIC tvtx-20250630_g1.jpg GRAPHIC 60227
  Complete submission text file 0001438533-25-000046.txt   9025137

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvtx-20250630.xsd EX-101.SCH 56888
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tvtx-20250630_cal.xml EX-101.CAL 96639
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tvtx-20250630_def.xml EX-101.DEF 300835
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvtx-20250630_lab.xml EX-101.LAB 720178
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvtx-20250630_pre.xml EX-101.PRE 526873
98 EXTRACTED XBRL INSTANCE DOCUMENT tvtx-20250630_htm.xml XML 1193693
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 251190679
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)